Use of high-efficacy agents in MS: Updated data from AAN 2015

 

 

REVIEWER: Paul Giacomini, MD, FRCPC, Associate Director, Multiple Sclerosis Clinic, Montreal Neurological Hospital and Institute, Assistant Professor, Department of Neurology and Neurosurgery, McGill University, Canada

Switching studies
Effect on brain volume change
Updated safety data

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page